Stockscreener 앱 받기
2.37
4.87%
0.11
시간 외 거래:
2.32
-0.05
-2.11%
전일 마감가:
$2.26
열려 있는:
$2.25
하루 거래량:
60,483
Relative Volume:
0.18
시가총액:
$5.99M
수익:
-
순이익/손실:
$-7.32M
주가수익비율:
-5.4147
EPS:
-0.4377
순현금흐름:
$-5.99M
1주 성능:
-0.84%
1개월 성능:
-27.89%
6개월 성능:
-40.15%
1년 성능:
-73.22%
1일 변동 폭
$2.20
$2.37
1주일 범위
$2.10
$2.59
52주 변동 폭
$2.10
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
명칭
Mangoceuticals Inc
전화
(833) 626-4679
주소
15110 DALLAS PKWY, SUITE 600, DALLAS
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World
Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World
Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World
Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World
Comparing Mangoceuticals (MGRX) and Its Peers - Defense World
Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World
Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India
Reviewing Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World
Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World
Mangoceuticals (MGRX) versus Its Rivals Head to Head Review - Defense World
Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia
Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com
MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha
Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com
Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com
MangoRx faces lawsuit from Eli Lilly over medication - Investing.com
Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks
MangoRx faces lawsuit from Eli Lilly over medication By Investing.com - Investing.com UK
Critical Contrast: Mangoceuticals (MGRX) and Its Rivals - Defense World
Analyzing Mangoceuticals (MGRX) & Its Rivals - Defense World
Reviewing Mangoceuticals (MGRX) and Its Competitors - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals (MGRX) and Its Competitors Head-To-Head Review - Defense World
Mangoceuticals (MGRX) and The Competition Critical Contrast - Defense World
Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 - Wetaskiwin Times Advertiser
Mangoceuticals (MGRX) versus Its Competitors Financial Contrast - Defense World
Mangoceuticals, Inc. announced that it has received $0.15 million in funding - Marketscreener.com
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter - Benzinga
Contrasting Mangoceuticals (MGRX) and Its Competitors - Defense World
Head-To-Head Comparison: Mangoceuticals (MGRX) & The Competition - Defense World
Examining Mangoceuticals Inc (MGRX) more closely is necessary - US Post News
Mangoceuticals Inc (MGRX) Stock: A Year of Declines and Increases - The InvestChronicle
Upward Trajectory: Mangoceuticals Inc (MGRX) Posts a Slidee, Closing at 0.21 - The Dwinnex
Mangoceuticals Inc’s latest rating changes from various analysts - Knox Daily
Mangoceuticals Inc (MGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.21%
0.43%
자본화:
|
볼륨(24시간):